Eli Lilly & Co. Stock Prediction
AI-powered sentiment analysis and prediction trends for LLY, updated each market day.
LLY AI Sentiment
AI predicts Eli Lilly & Co. stock is likely to decrease over the next 10 market days.
Prediction date: Sept. 21, 2026
Exact scores are in the SharePreds app
The precise prediction score for this stock, with buy and sell targets and a stop loss, updated every market day.
About Eli Lilly & Co.
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio and Jaypirca for cancer; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
Sector
Exchange
Market Cap
$1,027,235,535,988
Cap Tier
Employees
50,000
Headquarters
INDIANAPOLIS, IN
Listed Since
July 9, 1970
Website
LLY Sentiment Trend: Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
LLY Volatility
Eli Lilly & Co. has shown moderate price volatility over the last 5 trading days. Moderate volatility indicates normal market activity with typical price fluctuations.
